about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Bal­ti­more sues Bio­gen, say­ing the com­pa­ny col­lud­ed with PBMs to min­i­mize gener­ic com­pe­ti­tion

8 months ago
Pharma
Law

SIGA fires for­mer NYC Covid ad­vi­sor af­ter se­cret record­ings de­tail pan­dem­ic-era par­ties

8 months ago
People
Pharma

Wave rides new Phase 2 DMD da­ta as it sets sights on ac­cel­er­at­ed ap­proval

8 months ago
R&D

Sanofi's Sar­clisa gets ap­proved as a first-line op­tion for some pa­tients new­ly di­ag­nosed with mul­ti­ple myelo­ma

8 months ago
Pharma
FDA+

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

8 months ago
Pharma
FDA+

Eu­ro­pean reg­u­la­tors reaf­firm Apel­lis’ re­jec­tion, add eight pos­i­tive rec­om­men­da­tions

8 months ago
FDA+

Ali­gos’ tri­al for oral MASH treat­ment suc­ceeds, but place­bo group shows odd trend

8 months ago
R&D

4DMT's gene ther­a­py re­duced need for stan­dard-of-care in­jec­tions to treat age-as­so­ci­at­ed vi­sion loss

8 months ago
R&D
Cell/Gene Tx

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

8 months ago
Pharma
FDA+

FDA ap­proves As­traZeneca’s asth­ma med­ica­tion Fasen­ra to treat rare au­toim­mune con­di­tion

8 months ago
Pharma
FDA+

Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

8 months ago
R&D
Pharma

Roivant makes an­oth­er deal, sell­ing Der­ma­vant to Organon for up to $1.2B

8 months ago
Deals

No­vo Nordisk signs ge­net­ic med­i­cine pact, ink­ing deal with NanoVa­tion

8 months ago
Deals

No­var­tis’ Kisqali snags FDA ap­proval to re­duce re­cur­rence in pa­tients with ear­ly forms of breast can­cer

8 months ago
Pharma
FDA+

Bad trip: How cul­ture con­flict and a need for cash near­ly broke Lykos

8 months ago
People
In Focus

Eu­ro­pean reg­u­la­tors for­ti­fy sin­gle-arm tri­al ad­vice, but un­der­score pref­er­ence for place­bo-con­trolled de­signs

8 months ago
FDA+

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

8 months ago
People
R&D

Au­rinia re­struc­tures board, bring­ing in Kevin Tang and keep­ing CEO

8 months ago
People

Neu­ro­crine culls Phase 2 neu­ropsych med af­ter fail­ing to val­i­date ear­li­er da­ta

8 months ago
R&D

J&J ex­pands Trem­fya in­to IBD with new FDA ap­proval

8 months ago
Pharma
FDA+

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

8 months ago
R&D

Adicet fol­lows oth­er cell ther­a­py biotechs in au­toim­mune piv­ot

8 months ago
R&D
Pharma

Roche's dual GLP-1/GIP re­sults show promis­ing weight loss, but al­so high rates of vom­it­ing

8 months ago
R&D
Pharma

Fed­er­al judge re­jects phar­ma in­dus­try’s re­quest to halt Mary­land’s 340B law

8 months ago
Pharma
Law
First page Previous page 6789101112 Next page Last page
A service from the Financial Times